Verified stock metrics
Aclaris Therapeutics Key Stock Metrics
Direct answer
Aclaris Therapeutics has 8 verified key metrics available.
Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked October 11, 2026.
Get free Aclaris Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Market capitalization
- $563.77M
- Price-to-book ratio
- 4.3x
- Return on equity
- -59.1%
- Dividend yield
- 0%
- 52-week price range
- $1.74 to $6.60
- Revenue growth
- -8.3%
- Profit margin
- 0%
- Debt-to-equity ratio
- 1.49%
Explore related company data
View Aclaris Therapeutics's market capitalizationView Aclaris Therapeutics's price-to-book ratioView Aclaris Therapeutics's return on equityView Aclaris Therapeutics's dividend yieldView Aclaris Therapeutics's 52-week price rangeView Aclaris Therapeutics's revenue growthView Aclaris Therapeutics's profit marginView Aclaris Therapeutics's debt-to-equity ratioReturn to Aclaris Therapeutics profile